Saxenda (liraglutide) Approved for chronic weight management, Saxenda is a GLP-1 agonist with a different active ingredient than Ozempic and Wegovy
I cross-checked the retatrutide dysesthesia signal (20.9% incidence at 12 mg in TRIUMPH-4) against the earlier Phase 2 adverse-event table, where it was not reported
By the time many of Rahmans patients see her, their diabetes has gone unmanaged for years and theyre suffering from severe complications like foot wounds or blindness
For many Georgetown residents, the body is hormonally wired to feel hungry more often and hold on to fat more aggressively than it should, no matter how disciplined the approach
This ensures that as individuals experience reduced appetite from the medications, among other side effects, they are simultaneously adopting a healthier lifestyle, which is essential for long-term well-being and weight management, she said